Streetbeat News

Stock Prices

MAR

Marriott International announced at The Americas Lodging Investment Summit significant growth in its global signings, with a 52% increase in organic rooms signed in 2023 compared to 2022. Additionally, the company achieved a net rooms growth of 4.7% in 2023.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 12:23 pm

BOH

Bank of Hawaii (NYSE:BOH) reported Q4 adjusted earnings per share (EPS) of $1.01, slightly beating the consensus estimate of $1.00. However, the company's quarterly sales of $158.07M fell short of the expected $161.51M. Compared to the same quarter last year, EPS decreased by 32.67%, and sales dropped by 13.11%.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 12:21 pm

ADM

ADSK

ARRY

DDOG

ELF

FSLY

LCII

LYFT

STNE

UBER

Wall Street analysts have updated their price targets and ratings for several companies. Needham raised Uber's price target to $71 with a Buy rating. Morgan Stanley increased e.l.f. Beauty's target to $168 but downgraded it to Equal-Weight. Baird downgraded ADM and cut its target to $61. Barclays downgraded ARRY and reduced its target to $15. Citigroup raised Fastly's target to $20 and upgraded it to Neutral. Goldman Sachs increased StoneCo's target to $21 and upgraded it to Buy. Keybanc raised Autodesk's target to $265 with an Overweight rating. Citigroup increased Datadog's target to $150 with a Buy rating. TD Cowen raised Lyft's target to $12 with a Market Perform rating. BMO Capital downgraded LCI Industries and lowered its target to $100.

Portfolio Pulse from Avi Kapoor

January 22, 2024 | 12:20 pm

CHRS

SDZNY

Coherus BioSciences, Inc. (NASDAQ:CHRS) has agreed to sell its ophthalmology franchise, including CIMERLI and its commercial infrastructure, to Sandoz for $170 million in cash, plus additional payment for product inventory. The deal encompasses the CIMERLI biologics license application, sales and reimbursement teams, product inventory, and commercial software.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 12:15 pm

LYFT

TD Cowen analyst John Blackledge has maintained a Market Perform rating on Lyft (NASDAQ:LYFT) and increased the price target from $10 to $12.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 12:11 pm

COMM

B of A Securities analyst Tal Liani downgraded CommScope Hldg Co (NASDAQ:COMM) from Neutral to Underperform and reduced the price target from $2.1 to $2.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 12:10 pm

DOGEUSD

FLOKIUSD

Dogecoin (DOGE) experienced a surge of over 10% following buzz around a payment feature on Elon Musk's 'everything app' X. A verified account for X Payments has been created, fueling rumors that DOGE will be used as a universal payment method on the platform. Analyst Johnny predicts DOGE could reach $0.10, while Peppe has added DOGE to his portfolio due to these speculations. Interest in similar coins like FLOKI is also expected to rise, with FLOKI's market value increasing from $266 million to $300 million. Despite the excitement, Dogecoin's price fell 4%, with significant liquidations occurring.

Portfolio Pulse from Mehab Qureshi

January 22, 2024 | 12:07 pm

LCII

BMO Capital analyst Tristan Thomas-Martin has downgraded LCI Industries (NYSE:LCII) from Market Perform to Underperform and reduced the price target from $105 to $100.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 12:07 pm

ADM

Goldman Sachs analyst Adam Samuelson downgraded Archer-Daniels Midland (ADM) from Buy to Neutral and reduced the price target from $90 to $67.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 12:05 pm

AAPL

Apple Inc. (AAPL) has opened pre-orders for its Vision Pro mixed reality headset, with accessories and support plan totaling $1,510. The cost of essential accessories and AppleCare+ is $1,200, equivalent to the price of an iPhone 15 Pro Max. Analyst Ming-Chi Kuo reports better than expected demand for Vision Pro, with sales between 160,000 to 180,000 units, but warns of potential demand drop-off. Jim Cramer expressed skepticism about the product's broad appeal due to its high price.

Portfolio Pulse from Rounak Jain

January 22, 2024 | 12:04 pm